Skip to main content

Table 1 Multivariate analysis of ROCK1 expression and clinicopathological characteristics in patients with vulvar SCC

From: ROCK1 as a novel prognostic marker in vulvar cancer

Variables

Category

n

Hazard ratio for survival

95.0% CI

p

Histologic types

SCC1, SCC2, Verrucous Ca (1)

76

1

1

0.6177

SCC3, Basaloid Ca, Sarcomatoid Ca(2)

20

0.78

0.30 - 2.05

FIGO stage

IA, IB, II (1)

54

1

1

0.2083

IIA, IIIB, IIIC, IVA, IVB (2)

40

1.62

0.76 - 3.47

HPV

Absent (0)

50

1

1

0.2238

Present (1)

46

0.63

0.30 - 1.33

Inflammatory infiltrate

Absent (0)

38

1

1

0.4964

Present (1)

58

0.77

0.36 - 1.64

Vascular Invasion

Absent (0)

74

1

1

0.0365*

Present (1)

17

2.22

1.03 - 4.77

Perineural invasion

Absent (0)

76

1

1

0.4178

Present (1)

12

1.43

0.60 - 3.38

ROCK1 CT

Weak expression

22

1

1

0.6653

Moderate expression

55

0.70

0.28 - 1.75

Strong expression

19

0.95

0.34 - 2.67

ROCK1 IF

Weak expression

8

1

1

0.0054*

Moderate expression

53

0.22

0.08 - 0.60

 

Strong expression

35

0.30

0.11 -0.84

 
  1. Abbreviations: SCC squamous cell carcinomas, CI confidence interval, FIGO International Federation of Gynecology and Obstetrics, HPV human papillomavirus, SMD superficial and mid dermis, DDA deep dermis and subcutaneous tissues, CT central tumour and IF invasive front. *Statistically significant, p < 0.05.